Bio Pharma Dive

NOVEMBER 7, 2022

Buoyed by strong mid-stage study results, the biotech will soon start a cardiovascular outcomes trial of a drug designed to target a genetic risk factor called lipoprotein(a).

Drug Trials 288

Drug Trials Trials Genetics Drugs 288

Drug Discovery World

JULY 4, 2023

The post Patients achieve 19% weight loss in obesity drug trial appeared first on Drug Discovery World (DDW). After 46 weeks of treatment, up to 40% of people who reached the highest two doses of survodutide achieved a weight loss of at least 20%, versus 0% with placebo (actual treatment analysis).

Drug Trials 94

Drug Trials Trials Drugs 94

Bio Pharma Dive

DECEMBER 9, 2023

Study results disclosed at the American Society of Hematology meeting Saturday suggested potential for cell therapy in lupus and pointed out drug trial limitations.

Drug Trials 317

Drug Trials Trials Drugs 317

Bio Pharma Dive

DECEMBER 6, 2022

The decision not to run a Phase 3 trial of their medicine is the latest fallout from U.S. regulators’ recent moves to closely evaluate a class of drugs known as PI3 kinase inhibitors.

Drug Trials 161

Drug Trials Trials Drugs Regulation 161

Bio Pharma Dive

AUGUST 23, 2021

The decision, which follows the recommendation of a data monitoring committee, is yet another setback in the search for more treatments for the neurological disease.

Drug Trials 258

Drug Trials Trials Drugs 258

Drug Discovery World

NOVEMBER 30, 2023

The post Scleroderma drug trial shows up to 60% improvement appeared first on Drug Discovery World (DDW). It is important to advance safe and effective treatments through clinical development, given the limited therapeutic options for scleroderma patients.

Drug Trials 59

Drug Trials Trials Drugs Clinical Trials 59

pharmaphorum

DECEMBER 28, 2023

Cytokinetics rises on report that its aficamten drug improved symptoms in people with rare disease obstructive hypertrophic cardiomyopathy

Drug Trials 97

Drug Trials Drugs Trials 97

Bio Pharma Dive

JULY 17, 2023

The results come about two years after negative findings from an earlier phase of the study, and position the company to seek an approval in transthyretin amyloidosis cardiomyopathy.

Drug Trials 130

Drug Trials Trials Drugs 130

Drug Discovery World

JUNE 9, 2023

“The REBUILD study did not match the outcomes we saw in the exploratory Phase II study in this patient population; however, the overall outcome of this pivotal validation study is conclusive and we do not see a path forward for continuing the REBUILD trial,” said Peter Fernandes, Bellerophon’s Chief Executive Officer.

Drug Trials 52

Drug Trials Trials Drugs Clinical Trials 52

Bio Pharma Dive

MAY 24, 2022

The biotech plans to seek FDA approval for its soft-tissue tumor treatment after positive study results. But investors still sent the stock down by nearly 10%.

Drug Trials 130

Drug Trials FDA Approval Trials Drugs 130

Bio Pharma Dive

JULY 28, 2022

Important data from the APOLLO study of the biotech's drug Onpattro are due before the end of August, Alnylam said Thursday.

Drug Trials 169

Drug Trials Drugs Trials 169

pharmaphorum

MAY 19, 2022

.” Empatica’s range of wearables are well-established tools for studies in the pharma and healthcare industry, and have been used by many drug and medical device developers, including Sanofi, Roche, Novartis, Abbott, Bristol-Myers Squibb, and Johnson & Johnson.

Drug Trials 105

Drug Trials Trials Drugs Development 105

Drug Discovery World

MARCH 29, 2023

The post First patient dosed in ulcerative colitis drug trial appeared first on Drug Discovery World (DDW). This is measured by changes in laboratory values including C-reactive protein and faecal calprotectin, and changes in validated clinical and endoscopic scoring systems.

Drug Trials 52

Drug Trials Trials Drugs Clinical Trials 52

Roots Analysis

FEBRUARY 29, 2024

The post Zealand Pharma Stock Surge on Liver Disease Drug Trial Data appeared first on Blog. With a keen eye on the unfolding narrative of survodutide, the medical community eagerly awaits the next chapter in the fight against obesity and metabolic diseases.

Drug Trials 40

Drug Trials Trials Drugs Marketing 40

Bio Pharma Dive

OCTOBER 31, 2022

Bringing more diversity to clinical trials is a slow process and it takes time to get right. Learn how Worldwide Clinical Trials can diversify the reach of your orphan drug trial.

Clinical Trials 317

Clinical Trials Clinical Trials Drug Trials Trials 317

Bio Pharma Dive

JANUARY 10, 2023

Moderna’s Stéphane Bancel and Pfizer’s Albert Bourla hinted Monday at greater dealmaking to come for their companies, while Gilead gave investors an update on an important cancer drug trial.

Trials 285

Trials Drug Trials Development Vaccination 285

pharmaphorum

OCTOBER 27, 2020

Merimepodib is the subsidiary’s primary asset, and the biotech now says it is to offers to acquire or license the drug. The post BioSig abandons COVID-19 drug trial on safety concerns appeared first on. Image credit: Rocky Mountain Labs/NIH.

Drug Trials 98

Drug Trials Trials Drugs Contract Manufacturing 98

BioPharma Reporter

JULY 4, 2023

Sosei Heptares has dosed the first subject in a phase 1 trial evaluating HTLâ149, a first-in-class GPR52 agonist, which represents a novel mechanism of action for the treatment of schizophrenia and related neurological diseases.

Drug Trials 78

Drug Trials Trials Drugs Development 78

BioPharma Reporter

OCTOBER 4, 2022

Kibow Biotech is celebrating its 25th anniversary as the company pivots toward developing a drug based on its proprietary probiotic strains that benefit kidney disease suffers.

Drug Trials 98

Drug Trials Drugs Trials Development 98

pharmaphorum

MAY 7, 2021

The post Small Pharma stock market launch funds DMT-based depression drug trial appeared first on. “Given most other psychedelics focused companies have only been formed in the last 2 years, we believe our focus on IP since inception in 2015 gives us the potential to build a robust portfolio of valuable assets,” he added.

Drug Trials 96

Drug Trials Trials Marketing Drugs 96

STAT News

MARCH 29, 2023

Lupus is a disease long-plagued by failed clinical trials. And hopeful patients, many of them young women of color, are waiting — just three lupus drugs have been approved by the Food and Drug Administration in six decades. A key partnership is looking to change that.  

Drug Trials 116

Drug Trials Trials Drugs Engineer 116

pharmaphorum

FEBRUARY 21, 2024

Clinical research involves trial and error as part of the drug development process. Learn more about how to optimise drug trials and the important role of participants in clinical research.

Clinical Research 126

Clinical Research Trials Research Drug Trials 126

STAT News

FEBRUARY 17, 2023

Pfizer and partner Valneva are scrapping data from roughly half of the participants in a Phase 3 trial of a Lyme disease vaccine candidate after uncovering quality issues with a third-party clinical trial operator.

Trials 119

Trials Drug Trials Clinical Trials Clinical Trials 119

Medical Xpress

DECEMBER 29, 2022

A new drug designed to ward off Alzheimer's is being tested at more than 100 sites around the world, including the University of Pennsylvania.

Drug Trials 89

Drug Trials Drugs Trials Research 89

Outsourcing Pharma

APRIL 6, 2023

TWO US clinical investigator sites have been opened for a phase 1 clinical trial for patients with soft tissue sarcoma and the first patient has been dosed.

Drug Trials 98

Drug Trials Trials Clinical Trials Clinical Trials 98

Scienmag

JANUARY 19, 2022

New research suggests manufacturers of newly developed antidepressant drugs have become more forthcoming about clinical trials that don’t pan out.

Trials 83

Trials Drug Trials Clinical Trials Clinical Trials 83

BioSpace

FEBRUARY 15, 2021

According to a statement made by Cortexyme, the partial hold was placed on the development program for atuzaginstat after an FDA review of the trial data identified hepatic adverse events.

Drug Trials 107

Drug Trials Trials Drugs Development 107

pharmaphorum

MAY 14, 2021

The post Scepticism in press over Kintor’s COVID-19 US drug trial appeared first on. But one of the study’s authors, Brown University dermatology professor Carlos Wambler, dismissed critics and called findings “very encouraging”.

Drug Trials 52

Drug Trials Trials Drugs Dermatology 52

Pharma Times

DECEMBER 4, 2020

LYT-100 will be evaluated in patients with persistent symptoms caused by COVID-19

Drug Trials 119

Drug Trials Trials Drugs 119

Scienmag

DECEMBER 20, 2021

A clinical trial in which two test drugs failed to help patients with mild COVID-19 nevertheless had a silver lining: It proved the viability of a study model in which a medication’s potential arrhythmic side effects are safely, effectively monitored without the participants ever setting foot in a hospital or clinic.

Drug Trials 79

Drug Trials Trials Drugs Clinical Trials 79

BioSpace

OCTOBER 11, 2020

was convicted on 47 counts of fraud and drug related charges on Oct. A 41-year-old man from Richland, Wash. 1, according to the U.S. Justice Department’s Eastern District of Washington.

Drug Trials 117

Drug Trials Drugs Trials 117

Outsourcing Pharma

JANUARY 16, 2023

A Florida doctor has been sent to prison after submitting a false affidavit claiming she had screened children in a clinical study looking at the effectiveness of drugs given to children with asthma when she had not.

Drug Trials 59

Drug Trials Doctors Doctor Drugs 59

STAT News

SEPTEMBER 22, 2022

Hello, everyone, and how are you today? A dank cloudy cover greeted us this morning, but we are ignoring the gloom by keeping busy. After all, there is much to be done. There are deadlines to meet, a variety of reading material to digest, and calls to make. We trust you can relate.

Drug Trials 98

Drug Trials Trials Drugs 98

BioSpace

MARCH 22, 2021

Ionis Pharmaceuticals announced that its collaboration partner, Roche, was discontinuing dosing in the Phase III GENERATION HD1 trial of tominersen in manifest Huntington’s disease (HD).

Drug Trials 73

Drug Trials Trials Drugs 73

Outsourcing Pharma

AUGUST 29, 2022

The company reports dosing of the first subject in a Phase IIa proof-of-concept study investigating a drug for an autism spectrum disorder related condition.

Drug Trials 52

Drug Trials Drugs Trials Drug Delivery 52

BioSpace

JANUARY 28, 2021

Food and Drug Administration (FDA) has cleared an Investigational New Drug application that will allow Boston-based Vertex Pharmaceuticals to proceed with a clinical trial of its investigational stem cell-derived, fully differentiated pancreatic islet cell treatment for type 1 diabetes (.

Drug Trials 117

Drug Trials Trials Drugs Clinical Trials 117

BioTech 365

JULY 19, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Troubled Cytokinetics’ stock soars as gets much needed phase 2 heart drug trial win, plans late-stage effort by year’s end.Troubled Cytokinetics’ stock soars as gets much needed … Continue reading →

Drug Trials 40

Drug Trials Trials Drugs Research 40